Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients
TIL in NSCLC
Phase 1 other active
Quick answer
Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients for Respiratory tract diseases is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Respiratory tract diseases
- Phase
- Phase 1
- Modality
- other
- Status
- active